116 related articles for article (PubMed ID: 7700079)
21. Prediction of chemotherapy response in human leukemia using in vitro chemosensitivity test.
Hwang WS; Chen LM; Huang SH; Wang CC; Tseng MT
Leuk Res; 1993 Aug; 17(8):685-8. PubMed ID: 8355513
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of glycolysis modulates prednisolone resistance in acute lymphoblastic leukemia cells.
Hulleman E; Kazemier KM; Holleman A; VanderWeele DJ; Rudin CM; Broekhuis MJ; Evans WE; Pieters R; Den Boer ML
Blood; 2009 Feb; 113(9):2014-21. PubMed ID: 18978206
[TBL] [Abstract][Full Text] [Related]
23. In vitro cytotoxicity of mitoxantrone, daunorubicin and doxorubicin in untreated childhood acute leukemia.
Kaspers GL; Veerman AJ; Pieters R; van Zantwijk I; Klumper E; Hählen K; de Waal FC; van Wering ER
Leukemia; 1994 Jan; 8(1):24-9. PubMed ID: 8289494
[TBL] [Abstract][Full Text] [Related]
24. A randomized trial of induction therapy (daunorubicin, vincristine, prednisone versus daunorubicin, vincristine, prednisone, cytarabine and 6-thioguanine) in adult acute lymphoblastic leukemia with long-term follow-up: an Eastern Cooperative Oncology Group Study (E3486).
Wiernik PH; Cassileth PA; Leong T; Hoagland HC; Bennett JM; Paietta E; Oken MM;
Leuk Lymphoma; 2003 Sep; 44(9):1515-21. PubMed ID: 14565653
[TBL] [Abstract][Full Text] [Related]
25. Lack of cross-resistance between prednisolone and methotrexate in childhood acute lymphoblastic leukemia? A preliminary analysis.
Hegge IR; Kaspers GJ; Rots MG; Jansen G; Pieters R; Veerman AJ
Adv Exp Med Biol; 1999; 457():551-5. PubMed ID: 10500833
[TBL] [Abstract][Full Text] [Related]
26. Severe neurotoxicities in a case of Charcot-Marie-Tooth disease type 2 caused by vincristine for acute lymphoblastic leukemia.
Nishikawa T; Kawakami K; Kumamoto T; Tonooka S; Abe A; Hayasaka K; Okamoto Y; Kawano Y
J Pediatr Hematol Oncol; 2008 Jul; 30(7):519-21. PubMed ID: 18797198
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of cytotoxicity by flow cytometric drug sensitivity assay in childhood T-cell acute lymphoblastic leukemia.
Savaşan S; Buck S; Ozdemir O; Hamre M; Asselin B; Pullen J; Ravindranath Y
Leuk Lymphoma; 2005 Jun; 46(6):833-40. PubMed ID: 16019527
[TBL] [Abstract][Full Text] [Related]
28. Sensitivity of primary clonogenic blasts from acute lymphoblastic leukemia patients to an activated cyclophosphamide, viz., mafosfamide.
Uckun FM; Chandan-Langlie M; Dockham PA; Aeppli D; Sladek NE
Leuk Lymphoma; 1994 May; 13(5-6):417-28. PubMed ID: 8069187
[TBL] [Abstract][Full Text] [Related]
29. [Minimal residual disease analysis in acute lymphoblastic leukemia of childhood within the framework of COALL Study: results of an induction therapy without asparaginase].
zur Stadt U; Harms DO; Schlüter S; Jorch N; Spaar HJ; Nürnberger W; Völpel S; Gutjahr P; Schrappe M; Janka G; Kabisch H
Klin Padiatr; 2000; 212(4):169-73. PubMed ID: 10994545
[TBL] [Abstract][Full Text] [Related]
30. Expression of multidrug resistance (MDR) proteins and in vitro drug resistance in acute leukemias.
Fazlina N; Maha A; Jamal R; Zarina AL; Cheong SK; Hamidah H; Ainoon O; Zulkifli SZ; Hamidah NH
Hematology; 2007 Feb; 12(1):33-7. PubMed ID: 17364990
[TBL] [Abstract][Full Text] [Related]
31. [Acute lymphoblastic leukemia in children. Long survivals obtained with protocols C2-72 and D-74 (1972-1977)].
Ortega JJ; Javier G; Montagut JM; Torán N
An Esp Pediatr; 1986 Feb; 24(2):87-97. PubMed ID: 3516041
[TBL] [Abstract][Full Text] [Related]
32. [Treatment and prognosis after late relapse in childhood acute lymphoblastic leukemia].
Ikuta K; Fujioka K; Takahashi H; Sumita H; Sekiguchi H; Hanzawa N; Kai S; Kajigaya Y; Funabiki T; Okuyama T
Rinsho Ketsueki; 1993 Jun; 34(6):712-7. PubMed ID: 8366572
[TBL] [Abstract][Full Text] [Related]
33. Phase I trial of high-dose tamoxifen as a modulator of drug resistance in combination with daunorubicin in patients with relapsed or refractory acute leukemia.
Berman E; McBride M; Lin S; Menedez-Botet C; Tong W
Leukemia; 1995 Oct; 9(10):1631-7. PubMed ID: 7564501
[TBL] [Abstract][Full Text] [Related]
34. In vitro chemosensitivity of chronic lymphocytic leukemia B-cells to multidrug regimen (CEOP) compounds using the MTT colorimetric assay.
Morabito F; Messina G; Oliva B; Ramirez F; Callea V; Brugiatelli M; Nobile F
Haematologica; 1993; 78(4):213-8. PubMed ID: 8294052
[TBL] [Abstract][Full Text] [Related]
35. Adult acute lymphoblastic leukemia: results of an aggressive regimen in India.
Raje N; Pai S; Vaidya S; Gopal R; Parikh P; Saikia T; Pai V; Nadkarni K; Advani IM
Leuk Lymphoma; 1994 Jul; 14(3-4):285-90. PubMed ID: 7950917
[TBL] [Abstract][Full Text] [Related]
36. Potentiating role of previously administered agents in the combination chemotherapy of breast cancer.
Rosner D; Snyderman M; Nemoto T
Oncology; 1979; 36(4):160-3. PubMed ID: 471428
[TBL] [Abstract][Full Text] [Related]
37. Corticosteroid resistance is increased in lymphoblasts from adults compared with children: preliminary results of in vitro drug sensitivity study in adults with acute lymphoblastic leukaemia.
Maung ZT; Reid MM; Matheson E; Taylor PR; Proctor SJ; Hall AG
Br J Haematol; 1995 Sep; 91(1):93-100. PubMed ID: 7577660
[TBL] [Abstract][Full Text] [Related]
38. Daunorubicin and vincristine binding to plasma membrane vesicles from daunorubicin-resistant and wild type Ehrlich ascites tumor cells.
Sehested M; Bindslev N; Demant EJ; Skovsgaard T; Jensen PB
Biochem Pharmacol; 1989 Sep; 38(18):3017-27. PubMed ID: 2571333
[TBL] [Abstract][Full Text] [Related]
39. AML1 amplification in a child with acute lymphoblastic leukemia.
Alvarez Y; Coll MD; Bastida P; Ortega JJ; Caballín MR
Cancer Genet Cytogenet; 2003 Jan; 140(1):58-61. PubMed ID: 12550760
[TBL] [Abstract][Full Text] [Related]
40. [Clinical management of acute lymphocytic leukemia in adults. 1. Treatment of acute lymphocytic leukemia with VP (vincristine, prednisolone)--DVMP (daunorubicin, vincristine 6-mercaptopurine, prednisolone) regimen].
Takahashi I; Uchida K; Ohmoto E; Endo H; Oda Y; Fujimoto S; Hara M; Takaoka K; Watanabe S; Lai M; Kohi F; Kitajima K; Kimura I; Sanada H; Tokioka M; Adachi T; Yorimitsu S
Gan To Kagaku Ryoho; 1982 Jul; 9(6):1091-6. PubMed ID: 6964045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
